1 Conflicts of interest
ESC has received research support from DBV Technologies; has been a
member of advisory boards for Pfizer, Pediapharm, Leo Pharma, Kaleo,
DBV, AllerGenis, Sanofi Genzyme, Bausch Health, Avir Pharma; is a member
of the healthcare advisory board for Food Allergy Canada; was an expert
panel and coordinating committee member of the National Institute of
Allergy and Infectious Diseases (NIAID)-sponsored Guidelines for Peanut
Allergy Prevention; and was co-lead of the CSACI oral immunotherapy
guidelines.
SJ has been on speaker’s bureaus for Aralez, Novartis, Astra Zeneca, and
Sanofi, and on the advisory board for Sanofi.
MH has provided speaker services for Pfizer, Pediapharm, and has been
part of an advisory board for ALK and provides privately funded OIT.
VC has been a participant on advisory boards for Sanofi Genzyme, Bausch
Health, and ALK, speaker services for Aralez Pharmaceuticals and CSL
Behring.
DM has provided consultation and speaker services for Pfizer, Aimmune,
Kaleo, Merck, Covis and Pediapharm, and has been part of an advisory
board for Pfizer and Bausch Health. He sits on the editorial board for
the Journal of Food Allergy.
EA Section Head of Anaphylaxis/Food Allergy for the Canadian Society of
Allergy and Clinical Immunology; sits on steering committee for Canada’s
National Food Allergy Action Plan; moderator/speaker fees from Novartis,
GSK, Sanofi, AstraZeneca.
LS None
TW speaking engagements for Pfizer and Stallergenes Greer, Advisory
Board member for ALK and Leo Pharma
JP is the Section Head of Allied Health for the Canadian Society of
Allergy and Clinical Immunology; and sits on the steering committee for
Canada’s National Food Allergy Action Plan